Advertise

News
- Agencies
- Data/Analytics
- Campaigns
- Commercial
- Corporate
- Legal/Regulatory
- Media
- Payers
- Pipeline
- Technology
Digital deliverance: 4 ways marketers can make content more engaging for HCPs

Despite a rash of pessimism, HCPs remain engageable. Marketers must utilize open medical education hubs and CME town halls — among other tactics — to make content more engaging.
GSK digital leader brings tech flair

GSK consumer healthcare chief digital officer Marc Speichert talks about being a builder.
POC community makes good on promises of transparency and accountability

After a scandal with one of point of care's biggest players, we examine how the community is living up to its promise of greater transparency.
Series
Profiles in Creativity

This six-part series, produced by the MM&M Content Lab in partnership with Klick Health, tells personal stories of people using creativity to solve problems in healthcare.
Events
Videos
Resources
Careers
Magazine
- Latest Issue
- Issue Archive

October 19, 2004

Nonapprovable letter to Allergan

Share this content:

The FDA has issued a nonapprovable letter to Allergan for tazarotene capsules (oral tazarotene) for the treatment of psoriasis.

Share this content:

Recommended for you

Analysts: J&J doesn't need to worry about Sun ...

Sun Pharma's branded prostate cancer treatment Yonsa just received FDA approval.

Amgen and Novartis enlisted Arnold Worldwide, Wavemaker, and Starcom Media Group for its Speak Your Migraine campaign.

Novocure and Glue Advertising put on a Facebook Live event promoting the cancer treatment Optune in March.